Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies - Narratives (Details)

v3.26.3
Significant Accounting Policies - Narratives (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
customer
$ / shares
Sep. 30, 2025
USD ($)
customer
Sep. 30, 2026
USD ($)
customer
$ / shares
Sep. 30, 2025
USD ($)
customer
Dec. 31, 2025
$ / shares
Concentration Risk          
Number of customers (customer) | customer 4 5 4 5  
TOTAL OPERATING REVENUE $ 396,344 $ 345,253 $ 1,169,115 $ 1,074,266  
P3 ACO          
Concentration Risk          
Subsidiary, Ownership Percentage, Parent 20.00%   20.00%    
Capitated revenue          
Concentration Risk          
TOTAL OPERATING REVENUE $ 366,291 $ 341,555 $ 1,112,188 $ 1,062,796  
Part D Program Incentive Initiative          
Concentration Risk          
TOTAL OPERATING REVENUE $ 12,700   $ 12,700    
Class A Common Stock          
Concentration Risk          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001   $ 0.0001   $ 0.0001
Class V Common Stock          
Concentration Risk          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001   $ 0.0001   $ 0.0001
Four Health Plan Customer | Revenue | Customer Concentration          
Concentration Risk          
Percentage of total revenue (as a percent) 59.00% 76.00%      
Five Health Plan Customer | Revenue | Customer Concentration          
Concentration Risk          
Percentage of total revenue (as a percent)     61.00% 75.00%